Investors are directing capital toward industrial infrastructure, biotechnology, and AI-focused startups. Onodrim Industries secured $300 million in Series A funding at a $1.3 billion valuation to modernize European defense manufacturing. Meanwhile, Mavria raised $130 million in cumulative funding at a $1 billion valuation to develop factory-built data centers, with testing for its first unit expected in 2027.
In the biotechnology sector, T-Therapeutics closed a $133 million Series B round to advance cancer and autoimmune disease treatments. KyDo Therapeutics received additional seed funding to support its preclinical research on small-molecule cancer therapies. These companies face significant clinical and regulatory hurdles as they move toward potential patient trials.
The AI and materials science sectors also saw activity. Boson AI raised $70 million for interactive voice models, while GraphEnergyTech secured seed funding to develop graphene-based materials for electrical components. Additionally, Australian startup Vudoo raised AUD 22 million in Series B financing, and London-based Seva Money secured $5 million for cross-border services.
Consumer services and specialized technology remain areas of interest. Indian platform Pronto completed a $45 million Series B round earlier this year at a $200 million valuation. German satellite-imaging firm Marble Imaging also secured €6 million. Investors are prioritizing businesses that address complex operational problems through proprietary research or industrial execution.
